202Tip A Single-Arm, Open, Multicenter and Exploratory Clinical Study of Fluzopari Combined with Apatinib in Pts with Platinum-Sensitive Relapsed Ovarian Cancer First-Line Treated with a PARP Inhibitor
Annals of oncology(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要